At Westonci.ca, we make it easy for you to get the answers you need from a community of knowledgeable individuals. Get detailed and accurate answers to your questions from a dedicated community of experts on our Q&A platform. Get detailed and accurate answers to your questions from a dedicated community of experts on our Q&A platform.

the nurse provides care for a client diagnosed with hodgkin's disease. the client received cyclophosphamide. which laboratory value does the nurse report to the healthcare provider

Sagot :

The nurse will provide a platelet report to the healthcare provider for the client diagnosed with Hodgkin's disease who received cyclophosphamide.

The primary use of the potent medicine Cyclophosphamide is in cancer treatment. It belongs to the class of cytotoxic drugs called alkylating agents that stop the spread and proliferation of malignant cells.

Some skin disorders, especially those that are autoimmune or connected to an immunological sickness, have been shown to respond well to cyclophosphamide treatment.

A member of the group of medications known as alkylating agents is cyclophosphamide. Cyclophosphamide reduces or stops the growth of cancer cells in your body when used as a cancer treatment. Cyclophosphamide lowers your immune system when used to treat nephrotic syndrome.

Treatment for malignancies of the ovaries, breast, blood, lymphatic, and nervous systems with cyclophosphamide (mainly in children). Additionally, cyclophosphamide is used to treat mycosis fungoides, Hodgkin's disease multiple myeloma, and retinoblastoma, a bone marrow cancer that mostly affects children (tumors on the skin).

To learn more about cyclophosphamide please click on the given link: https://brainly.com/question/28482500

#SPJ4

We hope this information was helpful. Feel free to return anytime for more answers to your questions and concerns. We hope you found what you were looking for. Feel free to revisit us for more answers and updated information. We're glad you visited Westonci.ca. Return anytime for updated answers from our knowledgeable team.